 Source: Chepko Danil Vitalevich Shutterstock.com Invitae NYSE: NVTA stock is in the spotlight today after the company announced a collaboration with Simons Searchlight. Simons is an international research program that focuses on rare genetic neurodevelopmental disorders. 